Inhibiting GSTP1 activity has the potential to amplify chemotherapy’s cytotoxic effects by reducing drug detoxification and increasing oxidative stress in tumor cells (Ozcan et al. 2019, 2021). This evidence concerns the gene GSTP1 and neoplasm.